Central London Clinical Trials

As a patient recruitment service provider our central London location gives us a big advantage. We have easy and swift access to a diverse community of clinical trial participants, both patients and volunteers. Our Trials4Us recruitment service has a database of 310,000 registered trial participants – that’s larger than the population of Nottingham …and we have the biggest cohort of first-generation Japanese volunteers in Europe, currently more than 25,000.

Patient Recruitment Service Provider

Our patient recruitment service for healthy volunteers and patients is two to 10 times faster than other clinical research organisations. This means Richmond trials are ready to start sooner – and finish sooner, typically in three to six months.

Examples of our accelerated recruitment

Accurate costs projection. We conducted a FIH study of Lumasiran in March 2016. Our team helped to accelerate drug development using adaptive study design and provide accurate cost projections through efficient recruitment. Alnylam received marketing authorisation in April 2020.

In a study for Symptomatic Transthyretin Amyloid Cardiomyopathy, Richmond Pharmacology enrolled 11% of patients in a multi-centre study involving 104 global centres.

Reliability and operational scalability. Our in-house recruitment team enrolled 92 hypertensive patients for a global study on behalf of Alnylam, fulfilling 58% of the total cohort. Our patient networks enabled us to rapidly upscale recruitment and reduce the study timelines.

Richmond excels at getting trials underway fast. It is regularly Richmond that doses the first patients and after that the largest groups of early phase patients. This makes it easier for our sponsors to get additional UK sites set-up and to obtain approvals.

Rapid Drug Development

We quickly adapt patient recruitment strategies to suit the unique demands of individual trials, ensuring the more efficient use of your resources. Often we recruit more than our allotted cohort size in multi-centre studies, enabling our sponsors to complete enrolment early.